Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier

Journal of Clinical Investigation

Volumn 105, Issue 3, 2000, Pages 279-285

  Wijnholds, Jan ^a   De Lange, Elizabeth C M ^b   Scheffer, George L ^c   Van Den Berg, Dirk Jan ^b   Mol, Carla A A M ^a   Van Der Valk, Martin ^a   Schinkel, Alfred H ^a   Scheper, Rik J ^c   Breimer, Douwe D ^b   Borst, Piet ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOFOS; ETOPOSIDE; MULTIDRUG RESISTANCE PROTEIN;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CHOROID PLEXUS; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DISTRIBUTION; DRUG SENSITIVITY; DRUG TRANSPORT; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0033975098     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8267     Document Type: Article

References (52)

1. Gottesman, M.M., Hrycyna, C.A., Schoenlein, P.V., Germann, U.A., and Pastan, I. 1995. Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29:607-649.
2. Doyle, R.A., et al. 1998. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad Sci. USA. 95:15665-15670.
3. Allikmets, R., Schriml, L.M., Hutchinson, A., Romano-Sp:ca, V., and Dean. M. 1998. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58:5337-5339.
4. Miyake, K., et al. 1999. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Canser Res. 59:8-13.
5. Keppler, D., Leier, I., Jedlitschky, G , and König, J. 1998. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2. Chem. Biol. Interact. 111-112:153-161.
6. Cole, S.P., and Deeley, R.G. 1998. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays 20:931-940.
7. Cole, S.P.C., et al 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1650-1654.
8. Zaman, G.J.R., et al. 1994. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA. 91:8822-8826.
9. Cole, S.P.C., et al. 1994. Pharmalogical characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:5902-5910.
10. Ishikawa, T., Li, Z.S., Lu, Y.P., and Rea, P.A. 1997. The GS-X pump in plant, yeast, and animal cells: structure, function, and gene expression. Biosci. Rep. 17:189-207.
11. 4 and structurally related conjugates. J. Biol. Chem. 269:27807-27810.
12. Jedlitschky, G., et al. 1946. Transport of glutathione, glucuronate, and sulface conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56:988-994.
13. Müllet, M., et al. 1994. Overexpression of the gene encoding the multidrug resistance associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad Sci. USA. 91:13033-13037.
14. Wijnholds, J., et al. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3:1275-1279.
15. Zaman, G.J.R., et al. 1995. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA. 92:7690-7694.
16. Loe, D.W., Deeley, R.G., and Cole, S.P. 1998. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res. 58:5130-5136.
17. Renes, J., de Vries, E.G., Nienhius, E.F., Jansen, P.L., and Müller, M. 1999. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br. J. Pharmacol 126:681-688.
18. Rappa, G., Lorico, A., Flavell, R.A., and Sartorelli, A.C. 1997. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 57:5232-5237.
19. Schinkel, A.H., et al. 1997. Normal viability and altered pharmacokinetics in mice lacking Mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA. 94:4028-4033.
20. Schinkel, A.H., et al. 1994. Disruption of the mouse Mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:491-502.
21. Lorico, A., et al. 1997. Disruption of the murine MRP (Multidrug Resistance Protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57:5238-5242.
22. Sparreboom, A., et al. 1997. Limited oral bioavailability and active epithelial excretion of paclitaxel (taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA. 94:2011-2035.
23. de Lange, E.C., de Bock, G., Schinkel, A.H., de Boer, A.G., and Breimer, D.D. 1998. BBB transport and P-glycoprotein functionality using MDRIA ( / ) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123. Pharm. Res. 15:1657-1665.
24. Mayer, U., et al. 1997. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J. Clin. Invest. 100:2430-2436.
25. Cordon-Cardo, C., et al. 1989. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA. 86:695-698.
26. Wijnholds, J., et al. 1998. Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules againts drug-induced damage. J. Exp. Med. 188:797-808.
27. Flens, M.J., et al. 1996. Distribution of the multidrug resistance-associated protein (MRP) in normal and malignant human tissues. Am. J. Pathol. 148:1237-1247.
28. Hipfner, D.R., Gauldie, S.D., Deeley, R.G., and Cole, S.P. 1994. Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res. 54:5788-5792.
29. Wright, S.R., et al. 1998. Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung. Clin. Cancer Res. 4:2279-2289.
30. Mayer, R., et al. 1995. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from canalicular membrane in transport-deficient mutant hepatocytes. J. Cell Biol. 131:137-150.
31. Rao, V.V., et al. 1999. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Pro. Natl Acad. Sci. USA. 96:3900-3905.
32. Evers, R., et al. 1996. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J. Clin. Invest. 97:1211-1218.
33. Rubin, L.L., and Staddon, J.M. 1999. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22:11-28.
34. Spector, R., and Johanson, C.E. 1989. The mammalian choroid plexus. Sci. Am. 261:68-74.
35. Mihorat, T.H. 1976. Structure and function of the choroid plexus and other sites of cerebrospinal fluid formation. Int. Rev. Cytol. 47:225-289.
36. Angeletti, R.H., et al. 1997. The choroid plexus epithelium is the site of the organic anion transport protein in the brain. Proc. Natl. Acad. Sci. USA. 94:283-286.
37. Nishino, J., et al. 1999. Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein. J. Pharmacol. Exp. Ther. 290:289-294.
38. Spector, R. 1989. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J. Neurochem. 53:1667-1674.
39. Spector, R., and Goetzl, E.J. 1986. Leukotriene C4 transport and metabolism in the central nervous system. J. Neurochem. 46:1308-1312.
40. DiBenedetto, F.E., and Bito, L.Z. 1986. Transport of prostaglandins and other eicosanoids by the choroid plexus: its characterization and physiological significance. J. Neurochem. 46:1725-1731.
41. Spector, R., and Lorenzo, A.V. 1974. The effects of salicylate and probenecid on the cerebrospinal fluid transport of penicillin, aminosalicyclic acid and iodide. J. Pharmacol, Exp. Ther. 188:55-65.
42. Ogawa, M., Suzuki, H., Sawada, Y., Hanano, M., and Sugiyama, V. 1994. Kinetics of active efflux via choroid plexus of beta-lactam antibiotics from the CSF into the circulation. Am. J. Physiol. 266:R392-R399.
43. Nohjoh, T., et al. 1989. Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus. J. Pharmacol. Exp. Ther. 250:324-328.
44. Sawchuk, R.J., and Hedaya, M.A. 1990. Modeling the enhanced uptake of zidovudine (AZT) into cerebrospinal fluid. I. Effect of probenecid. Pharm. Res. 7:332-338.
45. Takasawa, K., Terasaki, T., Suzuki, H., and Sugiyama, Y. 1997. In vivo evidence for carrier-mediated efflux transport of 3́-izido-3́-deoxythymidine and 2́.3́-dideoxyinosine across the blood-brain barrier via a probenecidsensitive transport system. J. Pharmacol. Exp. 281:369-375.
46. Masereeuw, K., Jaehde, U., Langemeijer, M.W.E., de Boer, A.G., and Breimer, D.D. 1994. In vitro and in vivo transport of zidovudine (AZT) across the blood brain barrier and the effect of transport inhibitors. Pharm. Res. 11:324-330.
47. Kim, C.S., and Pritchard, J.B. 1993. Transport of 2,4,5-trichlorophenoxyacetic acid across the blood cerebrospinal fluid barrier of the rabbit. J. Pharmacol. Exp. Ther. 267:751-757.
48. Burgio, D.E., Gosland, M.P., and McNamara, P.J. 1996. Modulation effects of cyclosporine on etoposide pharmacokinetics and CNS distribution in the rat utilizing microdialysis. Biochem. Pharmacol. 51:987-992.
49. Pérez-Urizar, J., Picazo, Y.F., Navarro-González, B., Flores-Murrieta, F.J., and Castañeda-Hernandez, G. 1996. A new rapid, and economical high-performance liquid chromatographic assay with electrochemical detection for the determination of etoposide (VP-16) in human plasma samples. J. Liq. Chrom. & Rel. Technol. 19:939-947.
50. Peng, K.-C., et al. 1999. Tissue and cell distribution of the multidrug resistance-associated protein (MRP) in mouse intestine and kidney. J. Histochem. Cytochem. 47:757-767.
51. Faucheron, J.L. 1999. Toxicity of non-steroidal anti-inflammatory drugs in the large bowel. Eur. J. Gastroenterol. Hepatol. 11:389-392.
52. Panwala, C.M., Jones, J.C., and Viney, J.L. 1998. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene. Mdr1a, spontaneously develop colitis. J. Immunol 161:5733-5744.